Payer & Market Access Expert - Gross-to-Net & Formulary Strategy
This is the employer's own posting, not a copy on a job board.
What we know
Is it still open?
Confirmed still open
Last checked 21h ago — checked against the employer's own applicant tracking system, which is the company answering directly.
We re-read the employer's own applicant tracking system and the posting was still there. That is the company answering directly.
How old is it?
Posted 32d ago
The date the source published, not the day we noticed it (2026-08-14). Last seen at its source just now.
Is it remote?
Marked remote on the employer's board
Their board carries a remote setting on this posting — a field they filled in, not wording we read. The location field names somewhere specific, which is usually where the team or the entity sits.
Who may apply?
United States
The description agrees: it names United States.
What the ad says
…Location: Fully remote, United States…
Pay
$175–200/hr
Read out of the job description by us, not from a structured field. Shown in the posting's own currency and period; we never convert.
Carried by 1 source
-
workable employer's own board first seen 11d ago · last seen just now
The listing
This role is for one of our clients
Compensation: $175-$200 per hour
A leading biotech and pharmaceutical research organization is conducting a paid expert-evaluation initiative focused on improving how AI systems analyze commercial drugs and drug-development programs.
We are seeking an experienced Payer & Market Access Expert with strong knowledge of pricing, reimbursement, gross-to-net dynamics, rebates, and formulary strategy. You will help create and evaluate structured rubrics designed to assess whether AI-generated analyses accurately reflect real-world payer and market access practices.
This is a paid pilot engagement with the potential for continued work as the program expands.
Requirements
Key Responsibilities
- Create, review, and critique evaluation rubrics for analyzing commercial drugs and pharmaceutical development programs.
- Establish and pressure-test gross-to-net assumptions, including rebates, discounts, and other pricing considerations across relevant drug classes.
- Evaluate whether assumptions regarding formulary placement, coverage, utilization management, and payer behavior accurately reflect real-world market access practices.
- Assess payer and reimbursement considerations across different therapeutic areas and drug classes.
- Apply market access expertise consistently across the pilot's assigned portfolio of drugs and development programs.
- Identify unrealistic, incomplete, or unsupported assumptions and provide clear recommendations for improving evaluation criteria.
- Help ensure rubrics are practical, rigorous, and aligned with how experienced payer and market access professionals evaluate commercial opportunities.
Core Qualifications
- 5+ years of professional experience in market access, pricing and reimbursement, managed markets, payer strategy, or a closely related field.
- Currently based in the United States.
- Hands-on understanding of gross-to-net modeling, rebates, discounts, formulary tiering, and payer coverage dynamics.
- Familiarity with biotech and pharmaceutical drug-development programs and commercialization processes.
- Strong understanding of how payer behavior varies across drug classes, therapeutic categories, and commercial situations.
- Ability to critically evaluate assumptions and determine whether they are commercially realistic and supported by industry practice.
- Strong analytical reasoning and attention to detail.
- Excellent written communication skills, with the ability to clearly explain the rationale behind professional judgments.
- Comfortable working independently and providing structured feedback within defined evaluation frameworks.
Engagement Details
- Duration: Approximately 10–20 hours over a 1–2 week pilot.
- Location: Fully remote, United States.
- Engagement Type: Paid expert evaluation pilot.
- Potential Extension: Strong contributors may have opportunities for recurring engagements as the program expands.